Sargramostim
Showing 476 - 500 of 536
Hormone Refractory Prostate Cancer Trial in Columbus (Sargramostim, Docetaxel, Prednisone)
Terminated
- Hormone Refractory Prostate Cancer
- Sargramostim
- +2 more
-
Columbus, OhioVeeda Oncology
May 9, 2012
Melanoma (Skin) Trial in Detroit (aldesleukin, autologous tumor cell vaccine, muromonab-CD3)
Completed
- Melanoma (Skin)
- aldesleukin
- +4 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Apr 3, 2013
Leukemia Trial (biological, drug, procedure)
Completed
- Leukemia
- sargramostim
- +4 more
- (no location specified)
Jul 13, 2012
Lymphoma Trial in Atlanta (Mitoxantrone/Cyclophosphamide, Fludarabine, Rituximab and GM-CSF)
Terminated
- Lymphoma
- Mitoxantrone/Cyclophosphamide, Fludarabine, Rituximab and GM-CSF
-
Atlanta, GeorgiaEmory University Winship Cancer Institute
May 25, 2012
Colorectal Carcinoma Trial in Ottawa (Recombinant Vaccinia GM-CSF; RAC VAC GM-CSF (JX-594))
Terminated
- Colorectal Carcinoma
- Recombinant Vaccinia GM-CSF; RAC VAC GM-CSF (JX-594)
-
Ottawa, Ontario, CanadaOttawa Hospital and Research Institute (OHRI)
Apr 9, 2013
Prostate Cancer Trial in Durham (therapeutic autologous dendritic cells)
Terminated
- Prostate Cancer
- therapeutic autologous dendritic cells
-
Durham, North CarolinaDuke Comprehensive Cancer Center
Mar 19, 2013
Primary Refractory Neuroblastoma Trial in United States (MAb-3F8, Subcutaneous Granulocyte Macrophage Colony Stimulating Factor
Terminated
- Primary Refractory Neuroblastoma
- MAb-3F8
- +2 more
-
Phoenix, Arizona
- +14 more
Feb 28, 2013
Lymphoma, Neutropenia Trial in Chicago (epoetin alfa, filgrastim, recombinant flt3 ligand)
Terminated
- Lymphoma
- Neutropenia
- epoetin alfa
- +5 more
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center, Northwestern Univer
May 31, 2012
Nonneoplastic Condition Trial run by the CC (E1M184V peptide vaccine, incomplete Freund's adjuvant, sargramostim)
Completed
- Nonneoplastic Condition
- E1M184V peptide vaccine
- +3 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
May 1, 2012
Colorectal Carcinoma Trial in Worldwide (Endoxana, Leukine, IMA910, Endoxana, Leukine, IMA910, Aldara)
Completed
- Colorectal Carcinoma
- Endoxana, Leukine, IMA910
- Endoxana, Leukine, IMA910, Aldara
-
Bonheiden, Belgium
- +40 more
May 15, 2013
Leukemia Trial in Boston (autologous tumor cell vaccine, therapeutic autologous dendritic cells, tumor cell-derivative vaccine
Terminated
- Leukemia
- autologous tumor cell vaccine
- +2 more
-
Boston, MassachusettsCancer Research Center at Boston Medical Center
Jan 3, 2013
Breast Tumors, Metastases, Tumor Trial in Bethesda, Hackensack (recombinant fowlpox-CEA(6D)/TRICOM vaccine, recombinant
Terminated
- Breast Neoplasms
- Metastases, Neoplasm
- recombinant fowlpox-CEA(6D)/TRICOM vaccine
- +8 more
-
Bethesda, Maryland
- +1 more
Mar 20, 2012
Myasthenia Gravis Trial in Chicago (Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF))
Unknown status
- Myasthenia Gravis
- Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
-
Chicago, IllinoisUniversity of Illinois at Chicago, Department of Neurology
Mar 14, 2012
Breast Cancer, Colorectal Cancer, Lung Cancer Trial in Washington, Durham (denileukin diftitox, recombinant
Completed
- Breast Cancer
- +4 more
- denileukin diftitox
- +2 more
-
Washington, District of Columbia
- +1 more
Nov 8, 2012
Lymphoma, Non Hodgkin's Lymphoma Trial in San Juan (Cyclophosphamide, Doxorubicin, Vincristine and Prednisone)
Completed
- Lymphoma
- Non Hodgkin's Lymphoma
- Cyclophosphamide, Doxorubicin, Vincristine and Prednisone
-
San Juan, Puerto RicoHospital Auxilio Mutuo Cancer Center
Feb 3, 2012
Leukemia Trial in United States (biological, drug, procedure, radiation)
Completed
- Leukemia
- sargramostim
- +17 more
-
Aurora, Colorado
- +93 more
Nov 21, 2012
Lymphoma Trial in Houston (Campath-1H, G-CSF, GM-CSF)
Leukemia Trial in Baltimore (recombinant interferon alfa, sargramostim)
Terminated
- Leukemia
- recombinant interferon alfa
- sargramostim
-
Baltimore, MarylandJohns Hopkins Oncology Center
Jul 19, 2011
Leukemia Trial in Baltimore (sargramostim, therapeutic allogeneic lymphocytes, allogeneic bone marrow transplantation)
Terminated
- Leukemia
- sargramostim
- +3 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jul 19, 2011
Renal Cell Carcinoma Trial in Worldwide (Endoxana, IMA901, Leukine, IMA901 and Leukine)
Completed
- Renal Cell Carcinoma
- Endoxana, IMA901, Leukine
- IMA901 and Leukine
-
Salzburg, Austria
- +43 more
Jul 9, 2012
Leukemia Trial in Baltimore (autologous tumor cell vaccine, rituximab, cyclophosphamide)
Withdrawn
- Leukemia
- autologous tumor cell vaccine
- +2 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
May 1, 2012
Metastatic Cancer, Sarcoma Trial (biological, drug, other, procedure, radiation)
Completed
- Metastatic Cancer
- Sarcoma
- aerosol sargramostim
- +14 more
- (no location specified)
May 13, 2011
Melanoma (Skin) Trial in United States (MART-1 antigen, gp100 antigen, incomplete Freund's adjuvant)
Completed
- Melanoma (Skin)
- MART-1 antigen
- +5 more
-
Scottsdale, Arizona
- +31 more
Nov 5, 2011